NCT02503813

Brief Summary

One required examination for declaration of death by neurological criteria is the apnea challenge test. The apnea challenge test evaluates the medulla brainstem respiratory center response to a rise in CO2. The current guideline requires arterial sampling of CO2 and therefore either arterial puncture or arterial catheter placement for the examination. Arterial catheter is an invasive monitoring device and is not without complications. Recent studies have demonstrated that there is a direct correlation between peripheral venous and arterial blood gas measures and that peripheral venous CO2 measures may be used as alternatives to arterial CO2 measure.The purpose of this study is to evaluate brainstem response during the apnea challenge test to a rise in venous CO2 and correlate it with the rise in arterial measured CO2. The objective of this study is to demonstrate a similar rise between the venous and arterial CO2 during the apnea challenge test and eliminate the necessity of arterial blood sampling for the sole purpose of apnea challenge test in the future.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

July 16, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 21, 2015

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

October 3, 2022

Status Verified

July 1, 2015

Enrollment Period

2.2 years

First QC Date

July 16, 2015

Last Update Submit

September 29, 2022

Conditions

Keywords

brain deathapnea challenge test

Outcome Measures

Primary Outcomes (1)

  • Change in venous blood CO2 during apnea challenge test

    During apnea challenge test

Secondary Outcomes (1)

  • Change in End Tidal CO2 during apnea challenge test

    During apnea challenge test

Study Arms (1)

Experimental

EXPERIMENTAL

Venous blood gas will be obtained at the same time points as arterial blood gas in the apnea challenge test.

Procedure: venous blood gas

Interventions

Venous blood gas will be measured at the time of arterial blood gas measurement.

Experimental

Eligibility Criteria

Age1 Week+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 37 weeks gestation up to any adult age
  • Patients admitted to Pediatric Intensive Care unit (PICU), Neonatal Intensive Care Unit (NICU), Medical Intensive Care Unit (MICU) and Cardiothoracic Intensive Care Unit (CTICU)
  • Patients with irreversible brain injury where the attending physician will be performing death by neurological criteria examination as per hospital policy
  • Presence of arterial catheter or arterial blood sampling during apnea challenge test
  • Presence of central venous catheter or easily drawing peripheral intravenous catheter

You may not qualify if:

  • Age less or equal to 37 weeks gestation
  • Inability to perform apnea challenge test as determined by primary physician
  • Family request for Donation after Cardiac Death (DCD) or withdrawal of Life Sustaining Therapy
  • Bicarbonate infusion within 30 minutes of apnea challenge test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Long Beach Memorial and Miller Children's & Women's Hospital Long Beach

Long Beach, California, 90806, United States

Location

Related Publications (1)

  • Fathi A, Lake JL. Use of Venous Pco2 in Determination of Death by Neurological Criteria in Children. Pediatr Neurol. 2019 Apr;93:17-20. doi: 10.1016/j.pediatrneurol.2018.12.001. Epub 2018 Dec 19.

MeSH Terms

Conditions

Brain Death

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesComaUnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Critical Care Transport, Assoicate Medical Director, PICU

Study Record Dates

First Submitted

July 16, 2015

First Posted

July 21, 2015

Study Start

July 1, 2015

Primary Completion

September 1, 2017

Study Completion

September 1, 2017

Last Updated

October 3, 2022

Record last verified: 2015-07

Locations